Pulmocide’s Lead Drug Candidate Opelconazole (PC945) Granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA September 16, 2021
Immunitas Therapeutics Appoints Seng-Lai ‘Thomas’ Tan, Ph.D. as Chief Scientific Officer September 9, 2021
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress August 20, 2021
Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck on its WTX-124 INDUKINE™ Program August 19, 2021
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test August 19, 2021
